BiomedicalPublications

JCI Insight

American Society for Clinical Investigation·United States·ISSN 2379-3708

Open accessIn DOAJImmunology and Microbiology

JCI Insight is published by Browse by publisher as an open access journal (ISSN 2379-3708). The list article processing charge is $4,100. Typical time to publication is 6 wks. Its OpenAlex h-index is 174. Primary field: Immunology and Microbiology. It is listed in the Directory of Open Access Journals. Figures on this page are sourced from OpenAlex and DOAJ and should be confirmed on the journal’s own site before submission.

Cost to publish

$4,100

Open-access article processing charge, list price.

Checked · Journal fee page

Time to publication

6 wks

Fast for a peer-reviewed journal — check what review depth that implies.

h-index

174

OpenAlex citation statistic. Not a Journal Impact Factor.

2-year mean citedness

6.1

Average citations to articles from the previous two years.

What it costs to publish here

Publishing an open-access article in JCI Insight is listed at $4,100. No waiver policy is recorded in our sources, which does not mean none exists. Ask.

The journal's own fee page →

Peer review and licensing

Review modelAnonymous peer review (policy)
LicenceCC BY
Author keeps copyrightYes
Plagiarism screeningNot reported
Editorial boardPublished →
LanguagesEN

Verification checks

7 of 8 confirmed

These are facts we could verify in public records, not a verdict. A journal missing a check is not necessarily disreputable — many long-established subscription journals sit outside the open-access registries entirely. Use them as questions to ask, and confirm anything that matters directly with the journal before you submit.

  • Listed in the Directory of Open Access JournalsDOAJ applies a documented set of inclusion criteria.
  • Included in OpenAlex's curated core setOpenAlex flags well-established venues that appear across major indexes.
  • Peer review model publicly declaredAnonymous peer review
  • Publication charges stated up frontA journal that will not tell you the fee before submission is worth a second look.
  • Screens submissions for plagiarismReported to DOAJ by the journal.
  • Participates in a digital preservation schemeArchiving means the record survives if the publisher does not.
  • Assigns persistent identifiers (DOIs)Standard practice; its absence is unusual.
  • Still actively publishingMost recent indexed article: 2026.

Scope

The subjects JCI Insight publishes most, derived from the topics assigned to its indexed articles.

Immune Cell Function and InteractionT-cell and B-cell ImmunologyImmunotherapy and Immune ResponsesImmune cells in cancerPancreatic function and diabetesCancer Immunotherapy and BiomarkersCAR-T cell therapy researchSARS-CoV-2 and COVID-19 ResearchNeonatal Respiratory Health ResearchImmune Response and Inflammation

Publication record

Indexed articles5,371
Total citations224,289
i10-index3,966
Most recent indexed article2026
Open access since2020
All ISSNs2379-3708

Counts reflect what OpenAlex has indexed and will differ from the publisher's own figures. We do not show a founding year: OpenAlex's first-publication dates are distorted by mis-dated records — it puts PLoS ONE in 1806 — and we would rather omit a number than print one we cannot stand behind.